ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Apomab: An agonist monoclonal antibody directed against Death Receptor 5/TRAIL-Receptor 2 for use in the treatment of solid tumors
Expert Opinion on Biological Therapy
◽
10.1517/14712598.8.8.1167
◽
2008
◽
Vol 8
(8)
◽
pp. 1167-1176
◽
Cited By ~ 37
Author(s):
D Ross Camidge
Keyword(s):
Monoclonal Antibody
◽
Solid Tumors
◽
Death Receptor
◽
Trail Receptor
◽
Death Receptor 5
Download Full-text
Related Documents
Cited By
References
A phase I study of CS-1008 (humanized monoclonal antibody targeting death receptor 5 or DR5), administered weekly to patients with advanced solid tumors or lymphomas
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.3537
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 3537-3537
◽
Cited By ~ 18
Author(s):
M. N. Saleh
◽
I. Percent
◽
T. E. Wood
◽
J. Posey
◽
J. Shah
◽
...
Keyword(s):
Monoclonal Antibody
◽
Phase I
◽
Solid Tumors
◽
Phase I Study
◽
Death Receptor
◽
Advanced Solid Tumors
◽
Death Receptor 5
◽
Humanized Monoclonal Antibody
◽
Antibody Targeting
Download Full-text
Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation
BMC Immunology
◽
10.1186/1471-2172-13-40
◽
2012
◽
Vol 13
(1)
◽
pp. 40
Author(s):
Chunxia Qiao
◽
Meiyun Hu
◽
Leiming Guo
◽
Ming Lv
◽
Zhou Lin
◽
...
Keyword(s):
Monoclonal Antibody
◽
Complex Formation
◽
Death Receptor
◽
Structural Basis
◽
Death Receptor 5
Download Full-text
Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis
Hepatology
◽
10.1053/jhep.2003.50002
◽
2003
◽
Vol 37
(1)
◽
pp. 87-95
◽
Cited By ~ 152
Author(s):
P Taimr
Keyword(s):
Death Receptor
◽
Stellate Cells
◽
Trail Receptor
◽
Death Receptor 5
Download Full-text
Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)
Cancer Biotherapy & Radiopharmaceuticals
◽
10.1089/cbr.2009.0673
◽
2010
◽
Vol 25
(1)
◽
pp. 13-19
◽
Cited By ~ 103
Author(s):
Andres Forero-Torres
◽
Jatin Shah
◽
Tina Wood
◽
James Posey
◽
Ronda Carlisle
◽
...
Keyword(s):
Monoclonal Antibody
◽
Phase I
◽
Phase I Trial
◽
Death Receptor
◽
Death Receptor 5
◽
Humanized Monoclonal Antibody
◽
Antibody Targeting
Download Full-text
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-14-2780
◽
2015
◽
Vol 21
(12)
◽
pp. 2722-2729
◽
Cited By ~ 27
Author(s):
Andres Forero-Torres
◽
Katherine E. Varley
◽
Vandana G. Abramson
◽
Yufeng Li
◽
Christos Vaklavas
◽
...
Keyword(s):
Breast Cancer
◽
Monoclonal Antibody
◽
Phase Ii
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
Phase Ii Trial
◽
Death Receptor
◽
Death Receptor 5
Download Full-text
240 Molecular imaging of Death Receptor 5 (DR5) occupancy in-vivo by humanized monoclonal antibody CS-1008
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(10)71945-5
◽
2010
◽
Vol 8
(7)
◽
pp. 78
Author(s):
A.M. Scott
◽
F.T. Lee
◽
G.C. Cartwright
◽
G.J. O'Keefe
◽
R.A. Beckman
◽
...
Keyword(s):
Monoclonal Antibody
◽
Molecular Imaging
◽
Death Receptor
◽
Death Receptor 5
◽
Humanized Monoclonal Antibody
Download Full-text
Bile Acids Up-regulate Death Receptor 5/TRAIL-receptor 2 Expression via a c-Jun N-terminal Kinase-dependent Pathway Involving Sp1
Journal of Biological Chemistry
◽
10.1074/jbc.m309476200
◽
2003
◽
Vol 279
(1)
◽
pp. 51-60
◽
Cited By ~ 96
Author(s):
Hajime Higuchi
◽
Annette Grambihler
◽
Ali Canbay
◽
Steven F. Bronk
◽
Gregory J. Gores
Keyword(s):
Bile Acids
◽
Death Receptor
◽
Trail Receptor
◽
Death Receptor 5
◽
Dependent Pathway
Download Full-text
Melanoma-Directed Activation of Apoptosis Using a Bispecific Antibody Directed at MCSP and TRAIL Receptor-2/Death Receptor-5
Journal of Investigative Dermatology
◽
10.1016/j.jid.2015.11.009
◽
2016
◽
Vol 136
(2)
◽
pp. 541-544
◽
Cited By ~ 14
Author(s):
Yuan He
◽
Djoke Hendriks
◽
Robert van Ginkel
◽
Douwe Samplonius
◽
Edwin Bremer
◽
...
Keyword(s):
Bispecific Antibody
◽
Death Receptor
◽
Trail Receptor
◽
Death Receptor 5
Download Full-text
Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults
Expert Opinion on Biological Therapy
◽
10.1517/14712598.2011.610788
◽
2011
◽
Vol 11
(11)
◽
pp. 1519-1524
◽
Cited By ~ 6
Author(s):
Madhuri Bajaj
◽
Elisabeth I Heath
Keyword(s):
Monoclonal Antibody
◽
Death Receptor
◽
Death Receptor 5
◽
Advanced Malignancies
Download Full-text
Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model
Gynecologic Oncology
◽
10.1016/j.ygyno.2005.09.053
◽
2006
◽
Vol 101
(1)
◽
pp. 46-54
◽
Cited By ~ 31
Author(s):
J. Michael Straughn
◽
Patsy G. Oliver
◽
Tong Zhou
◽
Wenquan Wang
◽
Ronald D. Alvarez
◽
...
Keyword(s):
Cervical Cancer
◽
Monoclonal Antibody
◽
Radiation Therapy
◽
Death Receptor
◽
Death Receptor 5
◽
Cancer Model
◽
Anti Tumor Activity
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close